The Clinton Health Access Initiative (CHAI) has teamed up with UNITAID and the UK’s Department of International Development (DFID) to negotiate new price reductions on key antiretroviral (ARV) drug regimens. Today’s announcement means HIV/AIDS treatment will be more widely available as the newly reduced price ceilings will be available to most of the 70 countries […]
Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health, is arguably the U.S. government’s best-known scientist. John Donnelly interviewed Dr. Fauci for Science Speaks’ series on the 30th anniversary since the discovery of a virus that would turn out to be HIV, and he talked about everything from how he first learned of the disease, to his surprise in President George W. Bush’s commitment, to the unmet needs today to fight the pandemic. Read more…
HIV
As the federal Ending the HIV epidemic takes form, experts talk details, challenges: “How do we get there from here?” WASHINGTON, DC – Nearly four decades […]
Tuberculosis
Patients treated for multidrug-resistant tuberculosis with an experimental regimen containing a repurposed drug for a year had similar rates of successful outcomes as patients treated with […]
Research & Development
While a World Health Organization-led strategy aims to provide 1.4 billion doses of vaccine against yellow fever to achieve 80% vaccination coverage across countries by 2026 […]
Policy
The following is a guest post By Sharon Weir, Ph.D. of MEASURE Evaluation The Priorities for Local AIDS Control Efforts — PLACE –method aims to improve […]